Cargando…

The Problem of Abnormal Body Weight and Dyslipidemia as Risk Factors for Cardiovascular Diseases in Children and Adolescents with Type 1 Diabetes

Diabetes is a disease that affects many people around the world. Its complications are the cause of cardiovascular diseases (CVD) and increased mortality. That is why the search for predictive biomarkers is so important. The aim of the study was to show the prevalence of the problem and risk factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Noras, Katarzyna, Rusak, Ewa, Jarosz-Chobot, Przemysława
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355997/
https://www.ncbi.nlm.nih.gov/pubmed/34395631
http://dx.doi.org/10.1155/2021/5555149
_version_ 1783736862306729984
author Noras, Katarzyna
Rusak, Ewa
Jarosz-Chobot, Przemysława
author_facet Noras, Katarzyna
Rusak, Ewa
Jarosz-Chobot, Przemysława
author_sort Noras, Katarzyna
collection PubMed
description Diabetes is a disease that affects many people around the world. Its complications are the cause of cardiovascular diseases (CVD) and increased mortality. That is why the search for predictive biomarkers is so important. The aim of the study was to show the prevalence of the problem and risk factors in children and adolescents with type 1 diabetes. These patients are often overweight and obese, and the percentage of lipid disorders is particularly high. The discussed markers of CVD risk in type 1 diabetes include apolipoproteins (apo-B and apo-C3), modified forms of LDL, and the role of high-density lipoprotein (HDL). Recently, a new look at the vasoprotective effect of HDL has appeared, which due to its dysfunctional form in type 1 diabetes may not protect against cardiovascular risk. The HDL proteome in type 1 diabetes has an altered protein composition compared to the healthy population. Another direction of research is determining the importance of trace elements (mainly Mg) in the development of diabetes complications.
format Online
Article
Text
id pubmed-8355997
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-83559972021-08-12 The Problem of Abnormal Body Weight and Dyslipidemia as Risk Factors for Cardiovascular Diseases in Children and Adolescents with Type 1 Diabetes Noras, Katarzyna Rusak, Ewa Jarosz-Chobot, Przemysława J Diabetes Res Review Article Diabetes is a disease that affects many people around the world. Its complications are the cause of cardiovascular diseases (CVD) and increased mortality. That is why the search for predictive biomarkers is so important. The aim of the study was to show the prevalence of the problem and risk factors in children and adolescents with type 1 diabetes. These patients are often overweight and obese, and the percentage of lipid disorders is particularly high. The discussed markers of CVD risk in type 1 diabetes include apolipoproteins (apo-B and apo-C3), modified forms of LDL, and the role of high-density lipoprotein (HDL). Recently, a new look at the vasoprotective effect of HDL has appeared, which due to its dysfunctional form in type 1 diabetes may not protect against cardiovascular risk. The HDL proteome in type 1 diabetes has an altered protein composition compared to the healthy population. Another direction of research is determining the importance of trace elements (mainly Mg) in the development of diabetes complications. Hindawi 2021-08-02 /pmc/articles/PMC8355997/ /pubmed/34395631 http://dx.doi.org/10.1155/2021/5555149 Text en Copyright © 2021 Katarzyna Noras et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Noras, Katarzyna
Rusak, Ewa
Jarosz-Chobot, Przemysława
The Problem of Abnormal Body Weight and Dyslipidemia as Risk Factors for Cardiovascular Diseases in Children and Adolescents with Type 1 Diabetes
title The Problem of Abnormal Body Weight and Dyslipidemia as Risk Factors for Cardiovascular Diseases in Children and Adolescents with Type 1 Diabetes
title_full The Problem of Abnormal Body Weight and Dyslipidemia as Risk Factors for Cardiovascular Diseases in Children and Adolescents with Type 1 Diabetes
title_fullStr The Problem of Abnormal Body Weight and Dyslipidemia as Risk Factors for Cardiovascular Diseases in Children and Adolescents with Type 1 Diabetes
title_full_unstemmed The Problem of Abnormal Body Weight and Dyslipidemia as Risk Factors for Cardiovascular Diseases in Children and Adolescents with Type 1 Diabetes
title_short The Problem of Abnormal Body Weight and Dyslipidemia as Risk Factors for Cardiovascular Diseases in Children and Adolescents with Type 1 Diabetes
title_sort problem of abnormal body weight and dyslipidemia as risk factors for cardiovascular diseases in children and adolescents with type 1 diabetes
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355997/
https://www.ncbi.nlm.nih.gov/pubmed/34395631
http://dx.doi.org/10.1155/2021/5555149
work_keys_str_mv AT noraskatarzyna theproblemofabnormalbodyweightanddyslipidemiaasriskfactorsforcardiovasculardiseasesinchildrenandadolescentswithtype1diabetes
AT rusakewa theproblemofabnormalbodyweightanddyslipidemiaasriskfactorsforcardiovasculardiseasesinchildrenandadolescentswithtype1diabetes
AT jaroszchobotprzemysława theproblemofabnormalbodyweightanddyslipidemiaasriskfactorsforcardiovasculardiseasesinchildrenandadolescentswithtype1diabetes
AT noraskatarzyna problemofabnormalbodyweightanddyslipidemiaasriskfactorsforcardiovasculardiseasesinchildrenandadolescentswithtype1diabetes
AT rusakewa problemofabnormalbodyweightanddyslipidemiaasriskfactorsforcardiovasculardiseasesinchildrenandadolescentswithtype1diabetes
AT jaroszchobotprzemysława problemofabnormalbodyweightanddyslipidemiaasriskfactorsforcardiovasculardiseasesinchildrenandadolescentswithtype1diabetes